A forum for researchers, students and applicants in the field of cyclodextrin technology
Mallinckrodt Pharmaceuticals recently revealed findings of their completed registration trial for VTS-270 (Hydroxypropyl Betadex- HPBCD), a development product to treat
Federal Research Institute of Pediatric Hematology, Oncology and Immunology is about to launch a clinical study at Dmitry Rogachev National
A recently published patent application of Cell and Molecular Tissue Engineering LLC (WO2017180708) discloses a method of lowering the concentrations of
A recent paper in Drug Design, Development and Therapy gives an overview on the new strategies to combat antifungal drug
Cyclodextrins (CDs) have become a very common building-block for the design of new smart materials of different nature. This is
CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with
This report gives a market analysis of Cyclodextrins in the following aspects: Demand, Price, Cost, Sales Revenue, Gross, Gross Margin, Market
Dr. Wolz Zell GmbH (Geisenheim, Germany) sells capsules containing curcumin (15%) and gamma-cyclodextrin as dietary supplement. The molecular encapsulation of
A recently reported finding of Canadian researchers proved the specific effect of lysophosphatidic acid (LPA, see the structure below) by
Methylated α-CD (MeACD) loaded with exogenous lipids was used to replace the endogenous phospholipids and sphingolipids from cell plasma membrane
